Rankings
▼
Calendar
PEN Q2 2025 Earnings — Penumbra, Inc. Revenue & Financial Results | Market Cap Arena
PEN
Penumbra, Inc.
$13B
Q2 2025 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$339M
+13.4% YoY
Gross Profit
$224M
66.0% margin
Operating Income
$41M
12.0% margin
Net Income
$45M
13.3% margin
EPS (Diluted)
$1.15
QoQ Revenue Growth
+4.7%
Cash Flow
Operating Cash Flow
$45M
Free Cash Flow
$29M
Stock-Based Comp.
$14M
Balance Sheet
Total Assets
$1.7B
Total Liabilities
$381M
Stockholders' Equity
$1.3B
Cash & Equivalents
$422M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$339M
$299M
+13.4%
Gross Profit
$224M
$163M
+37.6%
Operating Income
$41M
-$81M
+150.4%
Net Income
$45M
-$60M
+175.2%
Geographic Segments
UNITED STATES
$261M
77%
Other Non-US
$79M
23%
← FY 2025
All Quarters
Q3 2025 →